Showing results (41-50 of 496) with videos related to
Sort By:
Pageof 50
Idrugs : the Investigational Drugs Journal|October 29, 2005
Inflammation 2005 - Seventh World Congress. Respiratory inflammationMichael J ParnhamEMBO Molecular Medicine|October 2, 2014
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in miceKatja Schmitz, Natasja de Bruin, Philipp Bishay, et al.International Journal of Molecular Sciences|January 3, 2017
R-Flurbiprofen Traps Prostaglandins within Cells by Inhibition of Multidrug Resistance-Associated Protein-4Ivonne Wobst, Lisa Ebert, Kerstin Birod, et al.Biochemical and Biophysical Research Communications|April 7, 2006
Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxibEllen Niederberger, Christine Manderscheid, Gerd GeisslingerInternational Journal of Molecular Sciences|September 21, 2017
Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic ReviewKatja Schmitz, Gerd Geisslinger, Irmgard TegederSchmerz (Berlin, Germany)|September 4, 2019
[Generating knowledge from complex data sets in human experimental pain research]Jörn Lötsch, Gerd Geisslinger, Carmen WalterExpert Opinion on Investigational Drugs|November 15, 2016
Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory painSabine Grösch, Ellen Niederberger, Gerd GeisslingerEuropean Journal of Pain (London, England)|June 30, 2010
Epigenetics in pain and analgesia: an imminent research fieldAlexandra Doehring, Gerd Geisslinger, Jörn LötschTrends in Pharmacological Sciences|February 25, 2012
Sniffing out pharmacology: interactions of drugs with human olfactionJörn Lötsch, Gerd Geisslinger, Thomas HummelTrends in Neurosciences|May 6, 2009
No NO, no pain? The role of nitric oxide and cGMP in spinal pain processingAchim Schmidtko, Irmgard Tegeder, Gerd GeisslingerPageof 50